Dr. Simon has worked with CHS for 14 years, assuming the CMO role in 2017. Effective Jan. 1, she will transition into a consulting position focused on cultivating new partnerships and advising the system’s management team on efforts to enhance innovation across care delivery, patient experience and clinician workflows, according to a Sept. 11 news release.
Dr. Simon is behind many partnerships that have led to better outcomes for patients and more streamlined workflows for clinicians, CHS leaders said in sharing the news of her transition. She played a key role in establishing the health system’s partnership with Mark Cuban Cost Plus Drugs, with the pharmaceutical company serving as a wholesale drug distributor for CHS ‘ 71 hospitals.
Once Dr. Simon transitions to the consulting arrangement, Miguel Benet, MD, will become president of clinical operations and CMO. He is currently the executive vice president of clinical operations.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.